Ekso Bionics Holdings, Inc. (EKSO) Financials

EKSO Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 20.1 million 11.1 million
Sept. 30, 2025 21.7 million 12.0 million
June 30, 2025 23.2 million 12.2 million
March 31, 2025 27.3 million 14.6 million

EKSO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -4.4 million 758000
Sept. 30, 2025 -2.0 million 259000
June 30, 2025 -3.4 million 207000
March 31, 2025 -2.0 million 225000

EKSO Net Income

No data available :(

EKSO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 1.2 million 945000 588000
Sept. 30, 2025 2.7 million 1.3 million 237000
June 30, 2025 5.2 million 3.7 million 806000
March 31, 2025 8.1 million 3.9 million 770000

EKSO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 2.4 million
Sept. 30, 2025 2.6 million
June 30, 2025 2.2 million
March 31, 2025 25.4 million

EKSO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 50000 641000 5.5 million 2.4 million
Sept. 30, 2025 50000 550000 3.4 million 1.3 million
June 30, 2025 40000 852000 3.9 million 1.7 million
March 31, 2025 10000 988000 4.3 million 1.7 million

EKSO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 3.1 million 1.5 million
Sept. 30, 2025 4.2 million 1.7 million
June 30, 2025 2.1 million 1.2 million
March 31, 2025 3.4 million 1.6 million

EKSO Revenue by Segment

Graph available only for paid members. Upgrade to see it.

EKSO

Price: $11.65

52 week price:
2.73
13.50

Payout Ratio Range:
-185.53%
-4.74%

Earnings Per Share: -4.91 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 30100

Ebitda: -6.6 million

Market Capitalization: 28.6 million

Links: